— Know what they know.
Not Investment Advice
Also trades as: GNS.L (LSE) · $vol 6M

GENSF OTC

Genus plc
1W: +1.5% 1M: -6.9% 3M: -6.9% YTD: -17.3% 1Y: -17.7% 3Y: -15.0% 5Y: -59.5%
$28.95
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Strong Sell · Power 40 · $1.9B mcap · 65M float · 0.0000% daily turnover · Short 100% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$1.9B
52W Range28.5-37.25
Volume300
Avg Volume14
Beta0.90
Dividend$0.42
Analyst Ratings
No analyst coverage
Company Info
CEOJorgen Kokke
Employees3,307
SectorHealthcare
IndustryBiotechnology
IPO Date2009-09-11
Matrix House
Basingstoke, HM RG21 4FF
GB
44 1256 347 100
About Genus plc

Genus plc is a global animal genetics company, with operations extending across North America, Latin America, the United Kingdom, broader Europe, the Middle East, Russia, Africa, and Asia. The firm organizes its business into three primary segments: Genus PIC, Genus ABS, and Genus Research and Development. Through its PIC brand, the company supplies breeding pigs and boar semen, enabling the production of swine with specific traits for pork processing. Furthermore, under the ABS, Genus, and Bovec labels, it provides bull semen and bovine embryos to facilitate the breeding of calves with targeted characteristics for dairy and beef output. Genus plc also extends specialized technical support to agricultural producers. Established in 1994, the company's headquarters are located in Basingstoke, United Kingdom.

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms